Alterity Therapeutics Limited (ASX:ATH)
Australia · Delayed Price · Currency is AUD 0.0080
+0.0010 (14.29%)
Mar 11, 2026, 4:10 PM AEST
Alterity Therapeutics Employees
Alterity Therapeutics had 9 employees as of June 30, 2025. The number of employees decreased by 1 or -10.00% compared to the previous year.
Employees
9
Change (1Y)
-1
Growth (1Y)
-10.00%
Revenue / Employee
737.38K AUD
Profits / Employee
-1.62M AUD
Market Cap
76.13M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 9 | -1 | -10.00% |
| Jun 30, 2024 | 10 | -1 | -9.09% |
| Jun 30, 2023 | 11 | -1 | -8.33% |
| Jun 30, 2022 | 12 | 1 | 9.09% |
| Jun 30, 2021 | 11 | -1 | -8.33% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Alterity Therapeutics News
- 2 days ago - Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit - GlobeNewsWire
- 6 days ago - Alterity Therapeutics Announces Appointment Of Daniel Claassen As Chief Medical Advisor - Nasdaq
- 9 days ago - Alterity Therapeutics Recognizes Multiple System Atrophy (MSA) Awareness Month in March and the Urgent Need for Disease-Modifying Treatments - GlobeNewsWire
- 5 weeks ago - Alterity Therapeutics (ATHE) Advances Phase 3 Program with Strong Financials - GuruFocus
- 5 weeks ago - Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update - GlobeNewsWire
- 6 weeks ago - Alterity Therapeutics (ATHE) Advances towards Phase 3 Trials with Promising MSA Treatment - GuruFocus
- 3 months ago - Alterity Therapeutics (ATHE) Pioneers Unique Approach to Neurodegeneration - GuruFocus
- 3 months ago - Alterity Therapeutics (ATHE) Focuses on Parkinson's Disease Research - GuruFocus